Start Forschung Abteilungen / AGs / Institute Molekulares Neuroimaging Publikationen

Publikationen: Molekulares Neuroimaging

Cumming P, Abi-Dargham A, Gründer G. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder. Behav Brain Res. 2021 398:113004.
Eap CB, Gründer G, Baumann P, Ansermot N, Conca A, Corruble E, Crettol S, Dahl ML, de Leon J, Greiner C, Howes O, Kim E, Lanzenberger R, Meyer JH, Moessner R, Mulder H, Müller DJ, Reis M, Riederer P, Ruhe HG, Spigset O, Spina E, Stegman B, Steimer W, Stingl J, Suzen S, Uchida H, Unterecker S, Vandenberghe F, Hiemke C. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants. World J Biol Psychiatry. 2021 22(8):561-628. Epub 2021 May 12.
Gründer G. Psychedelics: A New Treatment Paradigm in Psychiatry?. Pharmacopsychiatry. 2021 54(4):149-150. Epub 2021 Jun 24..
Gründer G, Bauknecht P, Klingberg S, Leopold K, Paulzen M, Schell S, Stengler K, Leucht S. Treatment Goals for Patients with Schizophrenia - A Narrative Review of Physician and Patient Perspectives. Pharmacopsychiatry. 2021 54(2):53-59. Epub 2020 Dec 8.
Gründer G, Cumming P. Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's disease". J Neurochem. 2021 156(5):560-562. Epub 2021 Jan 18.
Gründer G, Jungaberle H. The Potential Role of Psychedelic Drugs in Mental Health Care of the Future. Pharmacopsychiatry. 2021 54(4):191-199. Epub 2021 May 12..
Gründer G, Mertens L. Psilocybin for Depression. N Engl J Med. 2021 385(9):863.
Hart X, Eichentopf LE, Lense XL, Riemer T, Wesner KW, Hiemke C, Gründer G. Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews. Front Psychiatry. 2021 12:787043.
Kossmann C, Heller J, Brüne M, Schulz C, Heinze M, Cordes J, Mühlbauer B, Rüther E, Timm J, Gründer G, Juckel G. Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia. Psychiatr Q. 2021 29(1):177-191. Epub 2020 Jun 9.
Krause-Utz A, Mertens L, Renn JB, Lucke P, Wöhlke AZ, van Schie CC, Mouthaan J. Childhood Maltreatment, Borderline Personality Features, and Coping as Predictors of Intimate Partner Violence. J Interpers Violence. 2021 36(13-14):6693-6721. Epub 2018 Dec 31..
Kuzin M, Haen E, Hiemke C, Bochon B, Bochon K, Gründer G, Paulzen M, Schoretsanitis G. Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis. J Psychopharmacol. 2021 35(3):273-278. Epub 2021 Feb 5.
Meinhardt M, Giannone FG, Hirth N, Bartsch D, Spampinato SM, Kelsch W, Spanagel R, Sommer WH, Hansson AC. Disrupted circadian expression of beta-arrestin 2 affects reward-related µ-opioid receptor function in alcohol dependence. J Neurochem. 2021 Dec 16. [Epub ahead of print]
Meinhardt M, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv. 2021 7(47):eabh2399.
Mertens L, Preller KH. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders. Pharmacopsychiatry. 2021 54(4):176-190. Epub 2021 Jan 20..
Pfeifer P, Sebastian A, Buchholz HG, Kaller CP, Gründer G, Fehr C, Schreckenberger M, Tüscher O. Prefrontal and striatal dopamine D/D receptors correlate with fMRI BOLD activation during stopping. Brain Imaging Behav. 2021 Aug 17. [Epub ahead of print]
Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Gründer G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mössner R, Piacentino D, Steimer W, Zernig G, Hiemke C. Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs. Ther Drug Monit. 2021 43(1):79-102. Epub 2020 Nov 4.
Schoretsanitis G, Haen E, Conca A, Piacentino D, Ridders F, Hiemke C, Gründer G, Paulzen M. Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring Sample. Pharmacopsychiatry. 2021 54(1):31-35. Epub 2020 Aug 6.
Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Carpi F, Hiemke C, Gründer G, Paulzen M. Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions. Clin Pharmacokinet. 2021 60(12):1583-1589. Epub 2021 Jun 18.
Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Hiemke C, Gründer G, Paulzen M. Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database. Eur Arch Psychiatry Clin Neurosci. 2021 271(8):1437-1443. Epub 2021 Apr 5.
Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Hiemke C, Gründer G, Paulzen M. Effects of body weight, smoking status and sex on plasma concentrations of once-monthly paliperidone palmitate. Expert Rev Clin Pharmacol. 2021 Dec 17. [Epub ahead of print]
Surakka AS, Vengeliene V, Skorodumov I, Meinhardt M, Hansson AC, Spanagel R. Adverse social experiences in adolescent rats result in persistent sex-dependent effects on alcohol-seeking behavior. Alcohol Clin Exp Res. 2021 45(7):1468-1478.
de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopecek M, Švancer P, Olmos I, Ricciardi C, Iglesias-Garcia C, Iglesias-Alonso A, Spina E, Ruan CJ, Wang CY, Wang G, Tang YL, Lin SK, Lane HY, Kim YS, Kim SH, Rajkumar AP, González-Esquivel DF, Jung-Cook H, Baptista T, Rohde C, Nielsen J, Verdoux H, Quiles C, Sanz EJ, Las Cuevas C, Cohen D, Schulte PFJ, Ertuğrul A, Yağcıoğlu AEA, Chopra N, McCollum B, Shelton C, Cotes RO, Kaithi AR, Kane JM, Farooq S, Ng CH, Bilbily J, Hiemke C, López-Jaramillo C, McGrane I, Lana F, Eap CB, Arrojo-Romero M, Rădulescu FŞ, Seifritz E, Every-Palmer S, Bousman CA, Bebawi E, Bhattacharya R, Kelly DL, Otsuka Y, Lazary J, Torres R, Yecora A, Motuca M, Chan SKW, Zolezzi M, Ouanes S, Berardis D, Grover S, Procyshyn RM, Adebayo RA, Kirilochev OO, Soloviev A, Fountoulakis KN, Wilkowska A, Cubała WJ, Ayub M, Silva A, Bonelli RM, Villagrán-Moreno JM, Crespo-Facorro B, Temmingh H, Decloedt E, Pedro MR, Takeuchi H, Tsukahara M, Gründer G, Sagud M, Celofiga A, Ristic DI, Ortiz BB, Elkis H, Pacheco Palha AJ, LLerena A, Fernandez-Egea E, Siskind D, Weizman A, Masmoudi R, Saffian SM, Leung JG, Buckley PF, Marder SR, Citrome L, Freudenreich O, Correll CU, Müller DJ. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry. 2021 Dec 15. [Epub ahead of print]


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de